vs

Side-by-side financial comparison of Doximity, Inc. (DOCS) and HIVE Digital Technologies Ltd. (HIVE). Click either name above to swap in a different company.

Doximity, Inc. is the larger business by last-quarter revenue ($185.1M vs $93.1M, roughly 2.0× HIVE Digital Technologies Ltd.). Doximity, Inc. runs the higher net margin — 33.3% vs -98.1%, a 131.3% gap on every dollar of revenue. On growth, HIVE Digital Technologies Ltd. posted the faster year-over-year revenue change (218.6% vs 9.8%). Over the past eight quarters, HIVE Digital Technologies Ltd.'s revenue compounded faster (102.2% CAGR vs 25.2%).

Doximity is an online networking service for medical professionals. Launched in 2010, the platform offers its members curated medical news, telehealth tools, and case collaboration.

Mastech Digital, Inc. is a digital transformation and information technology (IT) services company headquartered in Pittsburgh, Pennsylvania, providing services to corporations across North America, Middle East, Asian, and Japan.

DOCS vs HIVE — Head-to-Head

Bigger by revenue
DOCS
DOCS
2.0× larger
DOCS
$185.1M
$93.1M
HIVE
Growing faster (revenue YoY)
HIVE
HIVE
+208.8% gap
HIVE
218.6%
9.8%
DOCS
Higher net margin
DOCS
DOCS
131.3% more per $
DOCS
33.3%
-98.1%
HIVE
Faster 2-yr revenue CAGR
HIVE
HIVE
Annualised
HIVE
102.2%
25.2%
DOCS

Income Statement — Q3 FY2026 vs Q3 FY2026

Metric
DOCS
DOCS
HIVE
HIVE
Revenue
$185.1M
$93.1M
Net Profit
$61.6M
$-91.3M
Gross Margin
89.9%
-27.1%
Operating Margin
38.9%
Net Margin
33.3%
-98.1%
Revenue YoY
9.8%
218.6%
Net Profit YoY
-18.1%
-234.0%
EPS (diluted)
$0.31
$-0.38

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DOCS
DOCS
HIVE
HIVE
Q4 25
$185.1M
$93.1M
Q3 25
$168.5M
$87.3M
Q2 25
$145.9M
$45.6M
Q1 25
$138.3M
Q4 24
$168.6M
$29.2M
Q3 24
$136.8M
$22.6M
Q2 24
$126.7M
$32.2M
Q1 24
$118.1M
Net Profit
DOCS
DOCS
HIVE
HIVE
Q4 25
$61.6M
$-91.3M
Q3 25
$62.1M
$-15.8M
Q2 25
$53.3M
$35.0M
Q1 25
$62.5M
Q4 24
$75.2M
$68.2M
Q3 24
$44.2M
$80.0K
Q2 24
$41.4M
$-18.3M
Q1 24
$40.6M
Gross Margin
DOCS
DOCS
HIVE
HIVE
Q4 25
89.9%
-27.1%
Q3 25
90.3%
4.7%
Q2 25
89.2%
-13.6%
Q1 25
89.5%
Q4 24
91.6%
-43.7%
Q3 24
90.0%
-66.1%
Q2 24
89.3%
-7.4%
Q1 24
89.4%
Operating Margin
DOCS
DOCS
HIVE
HIVE
Q4 25
38.9%
Q3 25
37.8%
Q2 25
37.4%
Q1 25
35.2%
Q4 24
47.4%
Q3 24
38.8%
Q2 24
36.4%
Q1 24
35.5%
Net Margin
DOCS
DOCS
HIVE
HIVE
Q4 25
33.3%
-98.1%
Q3 25
36.8%
-18.1%
Q2 25
36.5%
76.8%
Q1 25
45.2%
Q4 24
44.6%
233.2%
Q3 24
32.3%
0.4%
Q2 24
32.7%
-56.7%
Q1 24
34.4%
EPS (diluted)
DOCS
DOCS
HIVE
HIVE
Q4 25
$0.31
$-0.38
Q3 25
$0.31
$-0.07
Q2 25
$0.27
$0.18
Q1 25
$0.31
Q4 24
$0.37
$0.52
Q3 24
$0.22
$0.00
Q2 24
$0.21
$-0.17
Q1 24
$0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DOCS
DOCS
HIVE
HIVE
Cash + ST InvestmentsLiquidity on hand
$64.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$979.3M
$559.3M
Total Assets
$1.2B
$624.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DOCS
DOCS
HIVE
HIVE
Q4 25
$64.8M
Q3 25
$169.2M
Q2 25
$137.3M
Q1 25
$209.6M
Q4 24
$165.3M
$40.5M
Q3 24
$184.2M
$31.7M
Q2 24
$111.4M
Q1 24
$96.8M
Stockholders' Equity
DOCS
DOCS
HIVE
HIVE
Q4 25
$979.3M
$559.3M
Q3 25
$1.1B
$624.6M
Q2 25
$1.0B
$560.5M
Q1 25
$1.1B
Q4 24
$1.0B
$430.9M
Q3 24
$961.2M
$275.5M
Q2 24
$913.6M
$268.6M
Q1 24
$901.4M
Total Assets
DOCS
DOCS
HIVE
HIVE
Q4 25
$1.2B
$624.0M
Q3 25
$1.3B
$693.0M
Q2 25
$1.2B
$628.7M
Q1 25
$1.3B
Q4 24
$1.2B
$478.6M
Q3 24
$1.1B
$334.7M
Q2 24
$1.1B
Q1 24
$1.1B

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DOCS
DOCS
HIVE
HIVE
Operating Cash FlowLast quarter
$60.9M
$46.0M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
0.99×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DOCS
DOCS
HIVE
HIVE
Q4 25
$60.9M
$46.0M
Q3 25
$93.9M
$-10.6M
Q2 25
$62.1M
$10.2M
Q1 25
$98.5M
Q4 24
$65.2M
$-28.5M
Q3 24
$68.3M
$-2.2M
Q2 24
$41.2M
$-4.4M
Q1 24
$63.9M
Free Cash Flow
DOCS
DOCS
HIVE
HIVE
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$-55.5M
Q3 24
$-34.7M
Q2 24
Q1 24
FCF Margin
DOCS
DOCS
HIVE
HIVE
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
-189.9%
Q3 24
-153.4%
Q2 24
Q1 24
Capex Intensity
DOCS
DOCS
HIVE
HIVE
Q4 25
Q3 25
Q2 25
Q1 25
0.0%
Q4 24
0.0%
92.5%
Q3 24
0.0%
143.9%
Q2 24
0.0%
Q1 24
0.0%
Cash Conversion
DOCS
DOCS
HIVE
HIVE
Q4 25
0.99×
Q3 25
1.51×
Q2 25
1.16×
0.29×
Q1 25
1.58×
Q4 24
0.87×
-0.42×
Q3 24
1.55×
-26.94×
Q2 24
1.00×
Q1 24
1.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DOCS
DOCS

Subscription$175.4M95%
Service Other$9.7M5%

HIVE
HIVE

Segment breakdown not available.

Related Comparisons